These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2173283)

  • 1. [New 4-quinolones].
    Monova D; Belovezhdov N
    Vutr Boles; 1990; 29(2):1-10. PubMed ID: 2173283
    [No Abstract]   [Full Text] [Related]  

  • 2. [New quinolones].
    Matsumoto F; Morita M; Sato Y
    Nihon Rinsho; 1990 Oct; 48(10):2205-11. PubMed ID: 2177796
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.
    Mitscher LA
    Chem Rev; 2005 Feb; 105(2):559-92. PubMed ID: 15700957
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of the quinolones.
    Andersson MI; MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():1-11. PubMed ID: 12702698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antibiotics.
    Davies A
    Practitioner; 1990 Dec; 234(1497):1046, 1048, 1051. PubMed ID: 1963686
    [No Abstract]   [Full Text] [Related]  

  • 6. [How can we protect against broad-band pathogens? The situation with quinolone resistance].
    Kresken M; Hafner D
    Pharm Unserer Zeit; 2001; 30(5):436-45. PubMed ID: 11575181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemical structure of quinolones and their antibacterial activity. II. 4-quinolones: their occurrence in nature and biological properties].
    Milata V
    Ceska Slov Farm; 2000 Mar; 49(2):68-74. PubMed ID: 10953446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozenoxacin: a review of absorption, dermal exposure and toxicity, tolerability and safety studies.
    Gropper S
    Future Microbiol; 2014; 9(8 Suppl):S1-2. PubMed ID: 25209518
    [No Abstract]   [Full Text] [Related]  

  • 9. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
    Wiles JA; Bradbury BJ; Pucci MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolones.
    Chambers ST
    N Z Med J; 1995 Jul; 108(1003):273-7. PubMed ID: 7637926
    [No Abstract]   [Full Text] [Related]  

  • 11. Design, synthesis, structure-activity relationship and antibacterial activity series of novel imidazo fused quinolone carboxamides.
    Reddy GV; Kanth SR; Maitraie D; Narsaiah B; Rao PS; Kishore KH; Murthy US; Ravi B; Kumar BA; Parthasarathy T
    Eur J Med Chem; 2009 Apr; 44(4):1570-8. PubMed ID: 18775585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of in vitro data with newer quinolones.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):662-3. PubMed ID: 16312581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent progress in antimicrobial agents].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1988 Oct; 77(10):1519-23. PubMed ID: 2854150
    [No Abstract]   [Full Text] [Related]  

  • 14. Conformationally constrained analogs of N-substituted piperazinylquinolones: synthesis and antibacterial activity of N-(2,3-dihydro-4-hydroxyimino-4H-1-benzopyran-3-yl)-piperazinylquinolones.
    Emami S; Foroumadi A; Samadi N; Faramarzi MA; Rajabalian S
    Arch Pharm (Weinheim); 2009 Jul; 342(7):405-11. PubMed ID: 19544301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are the quinolones realising their clinical potential?
    Ball P
    J Chemother; 1989 Jul; 1(4 Suppl):664-5. PubMed ID: 16312582
    [No Abstract]   [Full Text] [Related]  

  • 17. Quinolones in 2005: an update.
    Van Bambeke F; Michot JM; Van Eldere J; Tulkens PM
    Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible development of resistance to quinolones. Its significance for general practice].
    Mohr CP
    Fortschr Med; 1988 Mar; 106(9):181-4. PubMed ID: 3286434
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions between 4-quinolone antibacterials and multivalent metal ions.
    Smith JT
    J Chemother; 1989 Jul; 1(4 Suppl):134-5. PubMed ID: 16312339
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.